주요메뉴 바로가기 본문 바로가기

주메뉴

IBS Conferences
Multi-Antioxidant Nanoparticles to Treat Sepsis 게시판 상세보기

Multi-Antioxidant Nanoparticles to Treat Sepsis

- From the energy sector to biology, ceria-zirconia nanoparticles remove free radicals and improve survival in animal models -

With an incidence of 31.5 million worldwide and a mortality of around 17%, sepsis remains the most common cause of death in hospitalized patients, even in industrialized countries where antibiotics and critical care facilities are readily available. While this disease begins as a serious infection, sepsis' life-threatening organ failure is due to an excessive inflammatory response. By overproducing oxygen free radicals, the immunity of the host itself paradoxically leads to an increase in morbidity and mortality.

A team of researchers from Center for Nanoparticle Research, within the Institute for Basic Science (IBS), with colleagues from the Seoul National University Hospital synthesized nanoparticles with superior antioxidant properties to treat sepsis in rats and mice by removing harmful oxygen radicals and reducing inflammatory responses. This study was chosen as 'Inside Cover', 'Hot Paper', and 'News Article' for press release in the journal Angewandte Chemie, in recognition of its importance.

Under normal physiological conditions, oxygen radicals, also called reactive oxygen species (ROS), are created as by-products of several cellular reactions and their concentration is counterbalanced by antioxidant enzymes, such as superoxide dismutase (SOD) and catalase (CAT). However in patients with severe infections, the production of ROS as well as reactive nitrogen species (RNS), increases dramatically, while the body's antioxidant capacity may be compromised. As a consequence, the ROS and RNS accumulation can lead to damages to DNA, proteins, and lipid membranes.

"All major diseases are related to ROS," explains HYEON Taeghwan, the director of the Center for Nanoparticle Research. "Cellular damage caused by ROS has been found not only in sepsis, but also in cancer, diabetes, cardiovascular disease, atherosclerosis, and neurodegenerative diseases, just to name a few."

Ceria nanoparticles replace the function of antioxidant enzymes. Cerium trivalent ions (Ce3+) play a decisive role in eliminating ROS. Previous studies from the same research center have shown that ceria nanoparticles are effective antioxidants in the treatment of ischemic stroke and Alzheimer's disease. However, concerns about their toxicity have been continuously raised. For this reason, IBS researchers went beyond their field to improve the performance of ceria nanoparticles, and so minimize the necessary dose. They found a solution in the energy sector, where ceria nanoparticles inserted with zirconium ions (Zr4+) are trialed for catalysts and fuel cells. Zirconium ions buffer the energetically unfavorable conversion of Ce4+ to Ce3+, regenerating the useful ion. "It was uncertain whether the introduction of zirconium ions could improve the antioxidant function of ceria nanoparticles in the blood. This is the first application of ceria–zirconia nanoparticles for pathophysiology," explains SOH Min, first co-author of the study.

Thanks to the addition of zirconium ions, the scientists could create a new type of nanoparticles, named 7CZ (containing 70% Ce ions and 30% Zr ions), with optimized nanoparticle size and Ce3+ content. The nanoparticles described in this study are smaller, just two nanometers in size. Moreover, they have a higher percent of Ce3+.

When tested in mice with sepsis, the survival rate increased 2.5 fold in the 7CZ NP-treated group compared to the control. Scientists found that 7CZ nanoparticles can infiltrate the damaged tissue and act locally at the infection site.

"Treating sepsis has been an old challenge for physicians worldwide," emphasizes LEE Seung-Hoon, professor of department of Neurology, Seoul National University Hospital. "This study shows the possibility of overcoming the limits of modern medicine with nanotechnology."

With regenerative antioxidant capacity, 7CZ NPs are expected to provide a new therapeutic strategy for sepsis by overcoming the drawbacks of conventional antioxidants. "Regulation of ROS level is critical to control an abnormal inflammatory response. ROS are short-lived, but constantly produced. Conventional anti-oxidants not only have to be introduced in multiple doses, but also cease to be effective when the body suffers from the breakdown of homeostasis. These nanoparticles, instead, are efficient with just one dose as mimicking regenerative natural enzyme in the body," enthuses KANG Dong-Wan, first co-author of the study.

Focusing on the mechanism of elimination of the nanoparticles, in relation to their size, the team is now studying how these nanoparticles are cleared from the body.


▲ Figure 1: Schematic representation of the study. A tailored amount of zirconium ions (Zr4+) in the 7CZ nanoparticles (7CZ NP) boost their performance as antioxidants: they are more efficient in converting Ce4+ into Ce3+ compared with the traditional ceria nanoparticles (Ceria NP), therefore a smaller dose suffice. After sepsis was induced in rats and mice with a puncture in the cecum (CLP), injection of 7CZ nanoparticles resulted in an increase in survival rate and a decrease in organ injuries.


▲ Figure 2: Ceria-zirconia nanoparticle (7CZ) have multi-antioxidant effects that mimic the function of the antioxidant enzymes superoxide dismutase (SOD) and catalase (CAT), and the capacity to remove hydroxyl radicals (HORAC). 7CZ nanoparticles reduce several reactive oxygen species (ROS): O2-, H2O2 and .OH.

Letizia Diamante

Notes for editors

- References
Min Soh, Dong-Wan Kang, Han-Gil Jeong, Dokyoon Kim, Do Yeon Kim, Wookjin Yang, Changyeong Song, Seungmin Baik, In-Young Choi, Seul-Ki Ki, Hyek Jin Kwon, Taeho Kim, Chi Kyung Kim, Seung-Hoon Lee, and Taeghwan Hyeon. Ceria–Zirconia Nanoparticles as Enhanced Multi-Antioxidant for Sepsis Treatment. Angewandte Chemie DOI: 10.1002/anie.201704904.

- Media Contact
For further information or to request media assistance, please contact: Mr. Shi Bo Shim, Head of Department of Communications, Institute for Basic Science (+82-42-878-8189, sibo@ibs.re.kr); Mr. Jung Gyu Kim, Global Officer, Department of Communications, Institute for Basic Science (+82-42-878-8172, jungkki1@ibs.re.kr); or Dr. Letizia Diamante, Science Writer and Visual Producer (+82-42-878-8260, letizia@ibs.re.kr).

- About the Institute for Basic Science (IBS)
IBS was founded in 2011 by the government of the Republic of Korea with the sole purpose of driving forward the development of basic science in South Korea. IBS has launched 28 research centers as of January 2017. There are nine physics, one mathematics, six chemistry, eight life science, one earth science and three interdisciplinary research centers.

Center for Nanoparticle Research

Publication Repository
현택환
Hyeon, Taeg Hwan 이메일 보내기 Center for Nanoparticle Research Publications
  • [Ciencias Médicas News] Researchers synthesize nanoparticles with superior antioxidant properties to treat sepsis
  • [Arirang] Korean researchers develop nanoparticle that can treat sepsis
  • [AsianScientist] A Nanoscale Solution To Sepsis
  • [ScienceNewsline] Multi-antioxidant Nanoparticles to Treat Sepsis
  • [PHYS.ORG] Ceria-zirconia nanoparticles as enhanced multi-antioxidants are effective in sepsis treatment
  • [Nanowerk] Multi-antioxidant nanoparticles to treat sepsis
  • [EurekAlert!] Multi-antioxidant nanoparticles to treat sepsis
  • [Infection Control Today] Multi-Antioxidant Nanoparticles to Treat Sepsis
  • [Wiley] Antioxidants Against Sepsis: Ceria-zirconia nanoparticles as enhanced multi-antioxidants are effective in sepsis treatment
  • [Scienmag] Multi-antioxidant nanoparticles to treat sepsis
  • [Alpha Galileo] Multi-Antioxidant Nanoparticles to Treat Sepsis
  • Research

    Are you satisfied with the information on this page?

    Content Manager
    Department of Communications : Han-Seob, Kim   042-878-8186
    Last Update 2017-11-15 02:43